The absence of class III β-tubulin is predictive of a favorable response to nab-paclitaxel and gemcitabine in patients with unresectable pancreatic ductal adenocarcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 12 January 2018 |
| Author/s |
author: Aya Naiki-Ito Itaru Naitoh |
| Publication date | January 12, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |